Back to search
FDAFDA · Food and drugs·Recall number D-0231-2026

darby dental supply, MEPIVACAINE, Mepivacaine HCI 3% (30mg/mL) Injection, [Mepivacaine HCI Injection, USP], packaged in a carton containing 50 single-dose Cartridges, 1.7 mL each, Rx only, Manufactured by Novocol Pharmaceutical of Canada, Inc., NDC 66467-9760-5.

Published December 24, 2025 · Recall initiated: October 31, 2025

Summary

FDA records drug Class II recall D-0231-2026, published December 24, 2025 and initiated October 31, 2025. Recalling firm: Novocol Pharmaceutical of Canada, Inc.; Status: Ongoing; Reported quantity: 5,520 Cartons; Lot: Lot: D05159G, expires: 07-31-2027. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Defective container: cracked/broken cartridges

What to do

Voluntary: Firm initiated · Letter

Get an email if MEPIVACAINE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
MEPIVACAINE
Manufacturer
Novocol Pharmaceutical of Canada, Inc.
Distributor
U.S.A. Nationwide
Lot
Lot: D05159G, expires: 07-31-2027
Risk classification
Class II
Area (FDA)
drug
Country
Canada

Related recalls

Questions about this recall

Was darby dental supply, MEPIVACAINE, Mepivacaine HCI 3% (30mg/mL) Injection, [Mepivacaine HCI Injection, USP], packaged in a carton containing 50 single-dose Cartridges, 1.7 mL each, Rx only, Manufactured by Novocol Pharmaceutical of Canada, Inc., NDC 66467-9760-5. recalled?

Yes. FDA published recall D-0231-2026 on December 24, 2025. Reported hazard: Defective container: cracked/broken cartridges

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: MEPIVACAINE.